| Advancements in radiomics, deep learning and AI pathological approaches are enabling a novel method of classifying responses from rectal cancer patients to chemoradiotherapy.
We spoke to Joanne Edwards from our Scotland Centre about the new project she’s co-leading that will use these advancements to enhance classification methods, integrating radiomics with other data such as clinical, pathological and genomic to inform the management of rectal cancer.
This project will see researchers, surgeons and engineers collaborate to convert scan images into high-dimensional data for analysis to support clinical decision-making and new drug development. |
